Shares of Vertex Pharmaceuticals (VRTX +6.3%) perk up after Credit Suisse upgrades the firm to...

|About: Vertex Pharmaceuticals In... (VRTX)|By:, SA News Editor

Shares of Vertex Pharmaceuticals (VRTX +6.3%) perk up after Credit Suisse upgrades the firm to Outperform all the way from Underperform. Analysts with the firm point to VRTX's 40% drop in share price since summer, calling it a "buying opportunity" ahead of 2012 pipeline catalysts.